KRMD - NASDAQ
KORU Medical Systems, Inc.
$4.05
+2.8%KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
At a Glance
Live SnapshotKORU Medical Systems, Inc. Management Team
Mr. Thomas Adams
Chief Financial Officer, Secretary & Treasurer
Compensation
$413,850
Mr. Christopher Pazdan
Chief Operating Officer
Mr. Rob Cannon
Interim Chief Commercial Officer
Ms. Linda M. Tharby
President, Chief Executive Officer & Director
Compensation
$718,326
KORU Medical Systems, Inc. Insider Positioning
During the last 12 months, insiders have purchased $2.52M worth of KRMD shares, with no selling activity reported.
3 Months
11.7K
45.42K
0
0.00
+45K
+$45K
3-6 Months
0
0.00
0
0.00
+0
+$0
6-9 Months
51.0K
202.70K
0
0.00
+203K
+$203K
9-12 Months
623.0K
2.27M
0
0.00
+2.3M
+$2.27M
Top Buyers
Kalbermatten Adam R
Officer: Chief Commercial Officer
$2.06M
French Donna
Director
$156K
Tharby Linda M
Director, Officer: Chief Executive Officer
$125K
Fletcher R John
Director, Other: Chairman Of The Board
$45K
Matin Shahriar
Director
$30K
Top Sellers
No selling activity
Insider Activity Analysis
Net Insider Sentiment
Strong bullish signal with $2.52M net buying. Insiders are aggressively accumulating shares, suggesting significant confidence in future prospects.
Buy/Sell Ratio
Perfect buy/sell ratio. Only buying activity with zero selling—the most bullish possible insider signal.
Recent Trend (3 Months)
Very strong recent buying momentum. Recent insider purchases significantly outpace sales, suggesting near-term optimism.
Insider Participation
5 insider buyers vs. 0 sellers. Broad-based buying across management team suggests widespread confidence.
Insider Activity Insight
Strong confluence of bullish signals: High buy/sell ratio, multiple insiders participating, and recent buying momentum all point to significant insider confidence. This level of coordinated buying often precedes positive developments.
SEC Filings
KRMD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2025 N/A | April 09, 2026 | December 31, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 04, 2025 | December 31, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | March 28, 2024 | December 31, 2023 | 2023 | |
DEF 14A DEF 14A 2023 N/A | March 29, 2023 | May 17, 2023 | 2023 | |
DEF 14A DEF 14A 2022 N/A | March 18, 2022 | May 06, 2022 | 2022 | |
DEF 14A DEF 14A 2020 N/A | April 05, 2021 | December 31, 2020 | 2020 | |
DEF 14A DEF 14A 2020 N/A | March 06, 2020 | March 06, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 08, 2019 | April 23, 2019 | 2019 | |
DEF 14A DEF 14A 2017 N/A | March 13, 2018 | December 31, 2017 | 2017 | |
DEF 14A DEF 14A 2016 N/A | July 28, 2016 | July 18, 2016 | 2016 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.